Header image
www.anco-online.org
 

 
ASCO/ONS Highlights 2011
ASCO/ONS Highlights 2011 summarized the major research and treatment advancements presented at this year’s ONS Congress and ASCO Annual Meeting. The program focused on breast, gastrointestinal, genitourinary, gynecological,and lung cancers as well as hematological malignancies. The faculty placed these developments in context as to their immediate clinical utility.

The meeting took place on Saturday, August 27th, at The Claremont Resort in Oakland.

Target Audience

ASCO/ONS Highlights 2011 was designed to meet the educational needs of oncologists, oncology nurses, oncology pharmacists, and other health-care professionals involved in the care of people with cancer.

Educational Objectives

At the conclusion of this educational activity, participants were able to:

• Review, summarize, and interpret new advances and implement changes in the treatment of breast, gastrointestinal, genitourinary, gynecological, and lung cancers and hematological malignancies presented at the 2011 ASCO Annual Meeting.

• Review, summarize, and interpret new advances and implement changes in oncology nursing presented at the 2011 ONS Congress.

Disclosure Statement

All faculty, authors, editors, and Program Planning Committee members participating in this activity disclosed any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that were discussed in an educational activity.

Presentations

ASCO Review 2011 (Hematological Malignancies)
Thomas G. Martin, MD, Univ of California, San Francisco

ASCO Updates 2011: Lung Cancer
Heather Wakelee, MD, Stanford Univ

ANCO's Best of ASCO 2011: GI Oncology Abstracts
Robin Kate Kelley, MD, Univ of Calfiornia, San Francisco

ONS Highlights
Carol S. Viele, RN, MS, CNS, OCN, Univ of Calif, San Francisco

Genitourinary Cancer: ASCO Update 2011
Primo Lara, Jr, MD, Univ of California, Davis

Gynecologic Cancer: ASCO/ONS Highlights 2011
Lee-may Chen, MD, Univ of California, San Francisco

ASCO Update 2011: Breast Cancer
Melinda L. Telli, MD, Stanford Univ

Supporters & Exhbitors

This educational activity was supported in part by Agendia, Allos Therapeutics, AMGEN, The Apothecary Shop, Astellas Oncology, AstraZeneca, Baxter BioScience, Bristol-Myers Squibb Oncology, Celgene, Cephalon Oncology, Clarient Diagnostic Services, Eisai, Genentech BioOncology, Genomic Health, Genzyme Oncology, GlaxoSmithKline Oncology, Janssen BIotech,Lilly Oncology, McKesson Specialty Care Solutions/US Oncology, Millennium, Novartis Oncology, Pfizer Oncology, Sanofi Aventis Oncology, and Spectrum Pharmaceuticals.